Combination of Tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species

Curcumin (Cur) has been extensively studied in several types of malignancies including colorectal cancer (CRC); however its clinical application is greatly affected by low bioavailability. Several strategies to improve the therapeutic response of Cur are being pursued, including its combination with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Sankpal, Umesh T., Nagaraju, Ganji Purnachandra, Gottipolu, Sriharika R., Hurtado, Myrna, Jordan, Christopher G., Simecka, Jerry W., Shoji, Mamoru, El-Rayes, Bassel, Basha, Riyaz
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4823099/
https://ncbi.nlm.nih.gov/pubmed/26672603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6553
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki